507 related articles for article (PubMed ID: 32934883)
1. Tumor-derived exosomes: the next generation of promising cell-free vaccines in cancer immunotherapy.
Naseri M; Bozorgmehr M; Zöller M; Ranaei Pirmardan E; Madjd Z
Oncoimmunology; 2020 Jun; 9(1):1779991. PubMed ID: 32934883
[TBL] [Abstract][Full Text] [Related]
2. Dual effect of DLBCL-derived EXOs in lymphoma to improve DC vaccine efficacy in vitro while favor tumorgenesis in vivo.
Chen Z; You L; Wang L; Huang X; Liu H; Wei JY; Zhu L; Qian W
J Exp Clin Cancer Res; 2018 Aug; 37(1):190. PubMed ID: 30103789
[TBL] [Abstract][Full Text] [Related]
3. The Double Face of Exosome-Carried MicroRNAs in Cancer Immunomodulation.
Alfonsi R; Grassi L; Signore M; Bonci D
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29652798
[TBL] [Abstract][Full Text] [Related]
4. TLR ligand loaded exosome mediated immunotherapy of established mammary Tumor in mice.
Yildirim M; Yildirim TC; Turay N; Bildik T; Ibibik B; Evcili I; Ersan PG; Tokat UM; Sahin O; Gursel I
Immunol Lett; 2021 Nov; 239():32-41. PubMed ID: 34418488
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cell-derived exosomes elicit tumor regression in autochthonous hepatocellular carcinoma mouse models.
Lu Z; Zuo B; Jing R; Gao X; Rao Q; Liu Z; Qi H; Guo H; Yin H
J Hepatol; 2017 Oct; 67(4):739-748. PubMed ID: 28549917
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of Anti-Leukemia Immunity by Leukemia-Derived Exosomes Via Downregulation of TGF-β1 Expression.
Huang F; Wan J; Hu W; Hao S
Cell Physiol Biochem; 2017; 44(1):240-254. PubMed ID: 29130994
[TBL] [Abstract][Full Text] [Related]
7. Dendritic cells loaded with tumor derived exosomes for cancer immunotherapy.
Liu H; Chen L; Peng Y; Yu S; Liu J; Wu L; Zhang L; Wu Q; Chang X; Yu X; Liu T
Oncotarget; 2018 Jan; 9(2):2887-2894. PubMed ID: 29416821
[TBL] [Abstract][Full Text] [Related]
8. Single-cell analysis of a tumor-derived exosome signature correlates with prognosis and immunotherapy response.
Wu J; Zeng D; Zhi S; Ye Z; Qiu W; Huang N; Sun L; Wang C; Wu Z; Bin J; Liao Y; Shi M; Liao W
J Transl Med; 2021 Sep; 19(1):381. PubMed ID: 34496872
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cell biology and its role in tumor immunotherapy.
Wang Y; Xiang Y; Xin VW; Wang XW; Peng XC; Liu XQ; Wang D; Li N; Cheng JT; Lyv YN; Cui SZ; Ma Z; Zhang Q; Xin HW
J Hematol Oncol; 2020 Aug; 13(1):107. PubMed ID: 32746880
[TBL] [Abstract][Full Text] [Related]
10. Glycosyl-phosphatidylinositol-anchored interleukin-2 expressed on tumor-derived exosomes induces antitumor immune response in vitro.
Zhang J; Zhang Y; Luo C; Xia Y; Chen H; Wu X
Tumori; 2010; 96(3):452-9. PubMed ID: 20845808
[TBL] [Abstract][Full Text] [Related]
11. Tumor cell-based vaccine: an effective strategy for eradication of cancer cells.
Sadeghi Najafabadi SA; Bolhassani A; Aghasadeghi MR
Immunotherapy; 2022 Jun; 14(8):639-654. PubMed ID: 35481358
[TBL] [Abstract][Full Text] [Related]
12. Exosomes Shuttle TREX1-Sensitive IFN-Stimulatory dsDNA from Irradiated Cancer Cells to DCs.
Diamond JM; Vanpouille-Box C; Spada S; Rudqvist NP; Chapman JR; Ueberheide BM; Pilones KA; Sarfraz Y; Formenti SC; Demaria S
Cancer Immunol Res; 2018 Aug; 6(8):910-920. PubMed ID: 29907693
[TBL] [Abstract][Full Text] [Related]
13. Tumor-derived exosomes elicit tumor suppression in murine hepatocellular carcinoma models and humans in vitro.
Rao Q; Zuo B; Lu Z; Gao X; You A; Wu C; Du Z; Yin H
Hepatology; 2016 Aug; 64(2):456-72. PubMed ID: 26990897
[TBL] [Abstract][Full Text] [Related]
14. DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy.
Tiptiri-Kourpeti A; Spyridopoulou K; Pappa A; Chlichlia K
Pharmacol Ther; 2016 Sep; 165():32-49. PubMed ID: 27235391
[TBL] [Abstract][Full Text] [Related]
15. Tumor-Related Exosomes Contribute to Tumor-Promoting Microenvironment: An Immunological Perspective.
Chen W; Jiang J; Xia W; Huang J
J Immunol Res; 2017; 2017():1073947. PubMed ID: 28642882
[TBL] [Abstract][Full Text] [Related]
16. Improved vaccine efficacy of tumor exosome compared to tumor lysate loaded dendritic cells in mice.
Gu X; Erb U; Büchler MW; Zöller M
Int J Cancer; 2015 Feb; 136(4):E74-84. PubMed ID: 25066479
[TBL] [Abstract][Full Text] [Related]
17. Exosome transportation-mediated immunosuppression relief through cascade amplification for enhanced apoptotic body vaccination.
Zhao G; Liu H; Wang Z; Yang H; Zhao H; Zhang Y; Ge K; Wang X; Luo L; Zhou X; Zhang J; Li Z
Acta Biomater; 2022 Nov; 153():529-539. PubMed ID: 36113726
[TBL] [Abstract][Full Text] [Related]
18. Exosome-based immunotherapy: a promising approach for cancer treatment.
Xu Z; Zeng S; Gong Z; Yan Y
Mol Cancer; 2020 Nov; 19(1):160. PubMed ID: 33183286
[TBL] [Abstract][Full Text] [Related]
19. Exosome nanovesicles as potential biomarkers and immune checkpoint signaling modulators in lung cancer microenvironment: recent advances and emerging concepts.
Khan NA; Asim M; Biswas KH; Alansari AN; Saman H; Sarwar MZ; Osmonaliev K; Uddin S
J Exp Clin Cancer Res; 2023 Aug; 42(1):221. PubMed ID: 37641132
[TBL] [Abstract][Full Text] [Related]
20. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
Ruffini PA; Neelapu SS; Kwak LW; Biragyn A
Haematologica; 2002 Sep; 87(9):989-1001. PubMed ID: 12217812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
